Regenerative therapy after cancer: What are the risks?

Tissue Engineering - Part B: Reviews

Volumn 16, Issue 6, 2010, Pages 567-575

  Donnenberg, Vera S ^a,b,c,d   Zimmerlin, Ludovic ^a,b   Rubin, Joseph Peter ^b,d   Donnenberg, Albert D ^a,b,d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Esophageal Surgery Institute   (United States)

^d MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BREAST RECONSTRUCTION; CANCER CELLS; CANCER RECURRENCE; CASE REPORTS; CELL LINES; CLINICAL ISOLATES; COCULTURE; COMPLEX SIGNAL; ENGINEERED TISSUES; FUNCTIONAL TISSUE; STEM CELL; TISSUE REGENERATION; TUMOR RESECTION; VASCULARIZATION; WOUND HEALING;

CELL CULTURE; STEM CELLS;

TUMORS;

ADIPONECTIN; ADIPSIN; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RANTES; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER REGRESSION; CANCER SURGERY; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; GRAFT SURVIVAL; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RISK FACTOR; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; REGENERATIVE MEDICINE; RISK FACTORS; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

ANIMALIA;

EID: 78649891908     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2010.0352     Document Type: Article

References (114)

1. Neuber, G.A. Fettransplantation. Chir Kongr Verhandl Deutsche Gesellschaft für Chirurgie 22, 66, 1893.
2. Czerny, V. Plastischer Ersatz Der Brustdruse durch ein Lipom. Chir Kong Verhandl 2, 216, 1895.
3. ASPRS. Report on autologous fat transplantation. ASPRS Ad-Hoc Committee on New Procedures, September 30, 1987. Plast Surg Nurs 7, 140, 1987.
4. Delay, E., Garson, S., Tousson, G., and Sinna, R. Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 29, 360, 2009.
5. Niechajev, I., and Sevcuk, O. Long-term results of fat transplantation: clinical and histologic studies. Plast Reconstr Surg 94, 496, 1994.
6. Peer, L.A. Loss of weight and volume in human fat grafts: with postulation of a "Cell Survival Theory." Plast Reconstr Surg 5, 217, 1950.
7. Yoshimura, K., Sato, K., Aoi, N., Kurita, M., Inoue, K., Suga, H., et al. Cell-assisted lipotransfer for facial lipoa-trophy: efficacy of clinical use of adipose-derived stem cells. Dermatol Surg 34, 1178, 2008.
8. Yoshimura, K., Sato, K., Aoi, N., Kurita, M., Hirohi, T., and Harii, K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthet Plast Surg 32, 48; discussion 6-7, 2008.
9. Matsumoto, D., Sato, K., Gonda, K., Takaki, Y., Shigeura, T., Sato, T., et al. Cell- assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 12, 3375, 2006.
10. Calabria, R., and Hills, B. Fat grafting: fact or fiction? Aesthet Surg J 25, 55, 2005.
11. Billings, E., Jr., and May, J.W., Jr. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83, 368, 1989.
12. Nguyen, A., Pasyk, K.A., Bouvier, T.N., Hassett, C.A., and Argenta, L.C. Comparative study of survival of autolo-gous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg 85, 378; discussion 87-89, 1990.
13. Moseley, T.A., Zhu, M., and Hedrick, M.H. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 118, 121S, 2006.
14. Zhu, M., Zhou, Z., Chen, Y., Schreiber, R., Ransom, J.T., Fraser, J.K., et al. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg 64, 222, 2010.
15. Miranville, A., Heeschen, C., Sengenes, C., Curat, C.A., Busse, R., and Bouloumie, A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110, 349, 2004.
16. Planat-Benard, V., Silvestre, J.S., Cousin, B., Andre, M., Nibbelink, M., Tamarat, R., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656, 2004.
17. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
18. Zimmerlin, L., Donnenberg, V.S., Pfeifer, M.E., Meyer, E.M., Peault, B., Rubin, J.P., et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 77A, 22, 2010.
19. Gronthos, S., Franklin, D.M., Leddy, H.A., Robey, P.G., Storms, R.W., and Gimble, J.M. Surface protein character-ization of human adipose tissue-derived stromal cells. J Cell Physiol 189, 54, 2001.
20. Strem, B.M., Hicok, K.C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R.E., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54, 132, 2005.
21. Daher, S.R., Johnstone, B.H., Phinney, D.G., and March, K.L. Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells 26, 2664, 2008.
22. Rubin, J.P., Bennett, J.M., Doctor, J.S., Tebbets, B.M., and Marra, K.G. Collagenous microbeads as a scaffold for tissue engineering with adipose-derived stem cells. Plast Reconstr Surg 120, 414, 2007.
23. Stacey, D.H., Hanson, S.E., Lahvis, G., Gutowski, K.A., and Masters, K.S. In vitro adipogenic differentiation of pre-adipocytes varies with differentiation stimulus, culture dimensionality, and scaffold composition. Tissue Eng Part A 15, 3389, 2009.
24. Leong, D.T., Nah, W.K., Gupta, A., Hutmacher, D.W., and Woodruff, M.A. The osteogenic differentiation of adipose tissue-derived precursor cells in a 3D scaffold/matrix environment. Curr Drug Discov Technol 5, 319, 2008.
25. Hodde, J.P., Record, R.D., Liang, H.A., and Badylak, S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 8, 11, 2001.
26. Zhu, Y., Liu, T., Ye, H., Song, K., Ma, X., and Cui, Z. Enhancement of adipose-derived stem cell differentiation in scaffolds with IGF-I gene impregnation unDer dynamic microenvironment. Stem Cells Dev 2010 Sep 6 [Epub ahead of print].
27. Ahmed, T.A., Dare, E.V., and Hincke, M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008 May 1 [Epub ahead of print].
28. Ota, T., Gilbert, T.W., Schwartzman, D., McTiernan, C.F., Kitajima, T., Ito, Y., et al. A fusion protein of hepatocyte growth factor enhances reconstruction of myocardium in a cardiac patch derived from porcine urinary bladDer matrix. J Thorac Cardiovasc Surg 136, 1309, 2008.
29. Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557, 2007.
30. Zhang, Y., Yao, F., Yao, X., Yi, C., Tan, C., Wei, L., et al. Role of CCL5 in invasion, proliferation and proportion of CD44\+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep 21, 1113, 2009.
31. Martin, F.T., Dwyer, R.M., Kelly, J., Khan, S., Murphy, J.M., Curran, C., et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010 Jan 20 [Epub ahead of print].
32. Pinilla, S., Alt, E., Abdul Khalek, F.J., Jotzu, C., Muehlberg, F., Beckmann, C., et al. Tissue resident stem cells produce CCL5 unDer the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 284, 80, 2009.
33. Yu, J.M., Jun, E.S., Bae, Y.C., and Jung, J.S. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 17, 463, 2008.
34. Muehlberg, F.L., Song, Y.H., Krohn, A., Pinilla, S.P., Droll, L.H., Leng, X., et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30, 589, 2009.
35. Zimmerlin, L., Donnenberg, A.D., Rubin, J.P., Basse, P., Landreneau, R.J., and Donnenberg, V.S. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng 2010 Jul 30 [Epub ahead of print].
36. Donnenberg, V.S., Luketich, J.D., Landreneau, R.J., DeLoia, J.A., Basse, P., and Donnenberg, A.D. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Found Symp Proc 5, 245, 2006.
37. Tasso, R., Augello, A., Carida, M., Postiglione, F., Tibiletti, M.G., Bernasconi, B., et al. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis 30, 150, 2009.
38. Sun, B., Roh, K.H., Park, J.R., Lee, S.R., Park, S.B., Jung, J.W., et al. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cy-totherapy 11, 289, 1p following 298, 2009.
39. Cousin, B., Ravet, E., Poglio, S., De Toni, F., Bertuzzi, M., Lulka, H., et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE 4, e6278, 2009.
40. Khakoo, A.Y., Pati, S., Anderson, S.A., Reid, W., Elshal, M.F., Rovira, I.I., et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203, 1235, 2006.
41. Qiao, L., Xu, Z., Zhao, T., Zhao, Z., Shi, M., Zhao, R.C., et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 18, 500, 2008.
42. Chanda, D., Isayeva, T., Kumar, S., Hensel, J.A., Sawant, A., Ramaswamy, G., et al. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clin Cancer Res 15, 7175, 2009.
43. Lu, Y.R., Yuan, Y., Wang, X.J., Wei, L.L., Chen, Y.N., Cong, C., et al. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther 7, 245, 2008.
44. Kang, S.G., Jeun, S.S., Lim, J.Y., Kim, S.M., Yang, Y.S., Oh, W.I., et al. Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells. Childs Nerv Syst 24, 293, 2008.
45. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytother-apy 8, 315, 2006.
46. Wexler, S.A., Donaldson, C., Denning-Kendall, P., Rice, C., Bradley, B., and Hows, J.M. Adult bone marrow is a rich source of human mesenchymal "stem" cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121, 368, 2003.
47. Brewster, A.M., Hortobagyi, G.N., Broglio, K.R., Kau, S.W., Santa-Maria, C.A., Arun, B., et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100, 1179, 2008.
48. Rene Gonzalez, R., Watters, A., Xu, Y., Singh, U., Mann, D., Rueda, B., et al. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res 11, R36, 2009.
49. Baldo, A., Sniderman, A.D., St. Luce, S., Avramoglu, R.K., Maslowska, M., Hoang, B., et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92, 1543, 1993.
50. Kucerova, L., Matuskova, M., Hlubinova, K., Altanerova, V., and Altaner, C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 9, 129, 2010.
51. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. Prospective identification of tumori-genic breast cancer cells. Proc Natl Acad Sci USA 100, 3983, 2003.
52. Dick, J.E. Breast cancer stem cells revealed. Proc Natl Acad Sci USA 100, 3547, 2003.
53. Abraham, B.K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., and Brauch, H. Prevalence of CD44\+/ CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11, 1154, 2005.
54. Sheridan, C., Kishimoto, H., Fuchs, R.K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C.H., et al. CD44\+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8, R59, 2006.
55. Kakarala, M., and Wicha, M.S. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 26, 2813, 2008.
56. Donnenberg, V.S., Donnenberg, A.D., Zimmerlin, L., Landreneau, R.J., Bhargava, R., Wetzel, R.A., et al. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom 2010 Apr 30 [Epub ahead of print].
57. Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., et al. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res 69, 836, 2009.
58. Quesenberry, P.J., Dooner, M.S., and Aliotta, J.M. Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Exp He-matol 38, 581, 2010.
59. Jones, P.A., and Laird, P.W. Cancer-epigenetics comes of age. Nat Genet 21, 163, 1999.
60. Dvorak, H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650, 1986.
61. Hofer, S.O., Molema, G., Hermens, R.A., Wanebo, H.J., Reichner, J.S., and Hoekstra, H.J. The effect of surgical wounding on tumour development. Eur J Surg Oncol 25, 231, 1999.
62. Warner, R.M., Wallace, D.L., Ferran, N.A., Erel, E., Park, A.J., Prinsloo, D.J., et al. Mastectomy scars following breast reconstruction: should routine histologic analysis be performed? Plast Reconstr Surg 123, 1141, 2009.
63. Hughes, E., McDermott, F., Polglase, A., and Johnson, W. Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery. Dis Colon Rectum 26, 571, 1983.
64. Winston, C.B., Chen, J.W., Fong, Y., Schwartz, L.H., and Panicek, D.M. Recurrent gallbladDer carcinoma along lap-aroscopic cholecystectomy port tracks: CT demonstration. Radiology 212, 439, 1999.
65. Faught, W., and Fung Kee Fung, M. Port site recurrences following laparoscopically managed early stage endome-trial cancer. Int J Gynecol Cancer 9, 256, 1999.
66. Agostini, A., Cohen, D., Cravello, L., Bretelle, F., Roger, V., and Blanc, B. Port-site recurrence following laparoscopic para-aortic lymphadenectomy for squamous carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol 98, 258, 2001.
67. Schnitt, S.J., Connolly, J.L., Harris, J.R., Hellman, S., and Cohen, R.B. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 53, 1049, 1984.
68. Thomas, E.D., Lochte, H.L., Jr., Cannon, J.H., Sahler, O.D., and Ferrebee, J.W. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 38, 1709, 1959.
69. Santos, G.W., Sensenbrenner, L.L., Burke, P.J., Colvin, M., Owens, A.H., Jr., Bias, W.B., et al. Marrow transplantation in man following cyclophosphamide. Transplant Proc 3, 400, 1971.
70. Pasquini, M.C., and Wang, Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2010. Available at: www.cibmtr.org.
71. Heimfeld, S., Fogarty, B., McGuire, K., Williams, S., and Be-renson, R.J. Peripheral blood stem cell mobilization after stem cell factororG-CSF treatment: rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system. Transplant Proc 24, 2818, 1992.
72. Stadtmauer, E.A., O'Neill, A., Goldstein, L.J., Crilley, P.A., Mangan, K.F., Ingle, J.N., et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. N Engl J Med 342, 1069, 2000.
73. Illouz, Y.G., and Sterodimas, A. Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthet Plast Surg 33, 706, 2009.
74. Yoshimura, K., Asano, Y., Aoi, N., Kurita, M., Oshima, Y., Sato, K., et al. Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J 16, 169, 2010.
75. Simmons, P.J., and Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 55, 1991.
76. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Pier-santi, S., Saggio, I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324, 2007.
77. Benayahu, D., Akavia, U.D., and Shur, I. Differentiation of bone marrow stroma-derived mesenchymal cells. Curr Med Chem 14, 173, 2007.
78. Park, P.C., Selvarajah, S., Bayani, J., Zielenska, M., and Squire, J.A. Stem cell enrichment approaches. Semin Cancer Biol 17, 257, 2007.
79. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., and Deliliers, G.L. Isolation of bone marrow mesen-chymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30, 783, 2002.
80. Delorme, B., Ringe, J., Gallay, N., Le Vern, Y., Kerboeuf, D., Jorgensen, C., et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111, 2631, 2008.
81. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
82. Vogel, W., Grunebach, F., Messam, C.A., Kanz, L., Brugger, W., and Buhring, H.J. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 88, 126, 2003.
83. Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33, 1402, 2005.
84. Lee, R.H., Kim, B., Choi, I., Kim, H., Choi, H., Suh, K., et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14, 311, 2004.
85. Roche, S., Delorme, B., Oostendorp, R.A., Barbet, R., Caton, D., Noel, D., et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 9, 223, 2009.
86. Noel, D., Caton, D., Roche, S., Bony, C., Lehmann, S., Casteilla, L., et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314, 1575, 2008.
87. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
88. Mitchell, J.B., McIntosh, K., Zvonic, S., Garrett, S., Floyd, Z.E., Kloster, A., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24, 376, 2006.
89. Traktuev, D.O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102, 77, 2008.
90. Ishimura, D., Yamamoto, N., Tajima, K., Ohno, A., Yamamoto, Y., Washimi, O., et al. Differentiation of adipose-derived stromal vascular fraction culture cells into chon-drocytes using the method ofcell sorting withamesenchymal stem cell marker. Tohoku J Exp Med 216, 149, 2008.
91. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
92. Delorme, B., Ringe, J., Pontikoglou, C., Gaillard, J., Lan-gonne, A., Sensebe, L., et al. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells 27, 1142, 2009.
93. Harris, L.J., Abdollahi, H., Zhang, P., McIlhenny, S., Tu-lenko, T.N., and Dimuzio, P.J. Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. J Surg Res 2009 Sep 4 [Epub ahead of print].
94. Kim, Y.M., Jeon, E.S., Kim, M.R., Jho, S.K., Ryu, S.W., and Kim, J.H. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth musclelike cells. Int J Biochem Cell Biol 40, 2482, 2008.
95. Dezawa, M., Ishikawa, H., Itokazu, Y., Yoshihara, T., Hoshino, M., Takeda, S., et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309, 314, 2005.
96. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93, 2002.
97. Planat-Benard, V., Menard, C., Andre, M., Puceat, M., Perez, A., Garcia-Verdugo, J.M., et al. Spontaneous cardio-myocyte differentiation from adipose tissue stroma cells. Circ Res 94, 223, 2004.
98. Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger, G., Bornhauser, M., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22, 377, 2004.
99. Woodbury, D., Schwarz, E.J., Prockop, D.J., and Black, I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61, 364, 2000.
100. Safford, K.M., Hicok, K.C., Safford, S.D., Halvorsen, Y.D., Wilkison, W.O., Gimble, J.M., et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294, 371, 2002.
101. Lee, K.D., Kuo, T.K., Whang-Peng, J., Chung, Y.F., Lin, C.T., Chou, S.H., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40, 1275, 2004.
102. Seo, M.J., Suh, S.Y., Bae, Y.C., and Jung, J.S. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 328, 258, 2005.
103. Spees, J.L., Olson, S.D., Ylostalo, J., Lynch, P.J., Smith, J., Perry, A., et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 100, 2397, 2003.
104. Brzoska, M., Geiger, H., Gauer, S., and Baer, P. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 330, 142, 2005.
105. Banfi, A., Bianchi, G., Notaro, R., Luzzatto, L., Cancedda, R., and Quarto, R. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 8, 901, 2002.
106. Simonsen, J.L., Rosada, C., Serakinci, N., Justesen, J., Sten-derup, K., Rattan, S.I., et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20, 592, 2002.
107. Zimmermann, S., Voss, M., Kaiser, S., Kapp, U., Waller, C.F., and Martens, U.M. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17, 1146, 2003.
108. Katz, A.J., Tholpady, A., Tholpady, S.S., Shang, H., and Ogle, R.C. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23, 412, 2005.
109. Lin, G., Garcia, M., Ning, H., Banie, L., Guo, Y.L., Lue, T.F., et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17, 1053, 2008.
110. Ksiazek, K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res 12, 105, 2009.
111. Noer, A., Boquest, A.C., and Collas, P. Dynamics of adi-pogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol 8, 18, 2007.
112. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
113. Min, S.Y., Kim, H.Y., Jung, S.Y., Kwon, Y., Shin, K.H., Lee, S., Kim, S.W., Kang, H.S., Yun, Y.H., and Lee, E.S. Oncological safety and quality of life associated with mastectomy and immediate breast reconstruction with a latissimus dorsi myocutaneous flap. Breast J 16, 356, 2010.
114. Rigotti, G., Marchi, A., Stringhini, P., Baroni, G., Galiè, M., Molino, A.M., Mercanti, A., Micciolo, R., and Sbarbati, A. Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesthetic Plast Surg 34, 475, 2010.